Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.69 - $1.21 $84,048 - $147,388
-121,809 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.02 - $3.8 $124,245 - $462,874
121,809 New
121,809 $145,000
Q2 2021

Aug 16, 2021

SELL
$5.01 - $7.48 $188,776 - $281,846
-37,680 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$7.19 - $14.95 $1.41 Million - $2.93 Million
-196,007 Reduced 83.88%
37,680 $282,000
Q4 2020

Feb 16, 2021

BUY
$6.66 - $14.66 $283,116 - $623,196
42,510 Added 22.24%
233,687 $2.54 Million
Q3 2020

Nov 16, 2020

SELL
$8.69 - $14.47 $358,479 - $596,916
-41,252 Reduced 17.75%
191,177 $1.69 Million
Q2 2020

Aug 14, 2020

BUY
$5.21 - $11.03 $769,053 - $1.63 Million
147,611 Added 174.03%
232,429 $2.48 Million
Q1 2020

May 15, 2020

SELL
$4.46 - $9.2 $277,675 - $572,782
-62,259 Reduced 42.33%
84,818 $503,000
Q4 2019

Feb 14, 2020

BUY
$4.52 - $10.1 $335,108 - $748,803
74,139 Added 101.65%
147,077 $1.02 Million
Q3 2019

Nov 14, 2019

SELL
$7.14 - $11.65 $152,710 - $249,170
-21,388 Reduced 22.67%
72,938 $757,000
Q2 2019

Aug 14, 2019

SELL
$5.5 - $9.75 $101,002 - $179,049
-18,364 Reduced 16.3%
94,326 $873,000
Q1 2019

May 15, 2019

BUY
$5.51 - $9.59 $131,182 - $228,318
23,808 Added 26.79%
112,690 $1.03 Million
Q4 2018

Feb 14, 2019

BUY
$5.55 - $11.34 $436,180 - $891,221
78,591 Added 763.69%
88,882 $496,000
Q3 2018

Nov 14, 2018

BUY
$9.74 - $12.92 $100,234 - $132,959
10,291 New
10,291 $123,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.